The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the Clinical Validity of 111 Gene-Disease Relationships.

Eleanor Broeren
Vanessa Gitau
Alicia Byrne
Pamela Ajuyah
Marie Balzotti
Jonathan Berg
Krista Bluske
B Monica Bowen
Matthew P Brown
Amanda Buchanan
Brendan Burns
Nicole J Burns
Anjana Chandrasekhar
Aditi Chawla
Jessica Chong
Maya Chopra
Amanda Clause
Marina DiStefano
Stephanie DiTroia
Marwa Elnagheeb
Amanda Girod
Himanshu Goel
Katie Golden-Grant
Thuong Ha
Ada Hamosh
Jennifer Huang
Madeline Hughes
Saumya Jamuar
Sylvia Kam
Akanchha Kesari
Ai Ling Koh
Rhonda Lassiter
Sarah Leigh
Gabrielle Lemire
Jiin Ying Lim
Alka Malhotra
Hannah McCurry
Becky Milewski
Shahida Moosa
Stephen A Murray, The Jackson Laboratory
Emma Owens
Emma Palmer
Brooke Palus
Mayher Patel
Revathi Rajkumar
Julie Ratliff
F Lucy Raymond
Bruno Della Ripa Rodrigues Assis
Samin Sajan
Zinayida Schlachetzki
Sarah Schmidt
Zornitza Stark
Samuel Strom
Julie Taylor
Courtney Thaxton
Devon Thrush
Sabrina Toro
Kezang Tshering
Nicole Vasilevsky
Bess Wayburn
Ryan Webb
Anne O'Donnell-Luria
Alison J Coffey

Abstract

PURPOSE: The Clinical Genome Resource (ClinGen) Gene Curation Expert Panels (GCEPs) have historically focused on specific organ systems or phenotypes; thus, the ClinGen Syndromic Disorders GCEP (SD-GCEP) was formed to address an unmet need.

METHODS: The SD-GCEP applied ClinGen's framework to evaluate the clinical validity of genes associated with rare syndromic disorders. 111 Gene-Disease Relationships (GDRs) associated with 100 genes spanning the clinical spectrum of syndromic disorders were curated.

RESULTS: From April 2020 through March 2024, 38 precurations were performed on genes with multiple disease relationships and were reviewed to determine if the disorders were part of a spectrum or distinct entities. 14 genes were lumped into a single disease entity and 24 were split into separate entities, of which 11 were curated by the SD-GCEP. A full review of 111 GDRs for 100 genes followed, with 78 classified as Definitive, 9 as Strong, 15 as Moderate, and 9 as Limited highlighting where further data are needed. All diseases involved two or more organ systems, while the majority (88/111 GDRs, 79.2%) had five or more organ systems affected.

CONCLUSION: The SD-GCEP addresses a critical gap in gene curation efforts, enabling inclusion of genes for syndromic disorders in clinical testing and contributing to keeping pace with the rapid discovery of new genetic syndromes.